LINC01168

Across TCGA pan-cancer cohorts, LINC01168 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC01168’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where LINC01168 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01168 is over-expressed in tumor, although a few such as UCEC and LUAD show the opposite, repressed pattern.

UCEC, LUAD, and KICH are the cancer types where LINC01168 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01168 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	−0.174	<.001	8	view →
LUAD	Male	All	−0.145	<.001	7	view →
KICH	All	All	−0.049	.001	7	view →
LUSC	All	All	−0.118	<.001	6	view →
KIRC	Male	II,III,IV	−0.033	<.001	6	view →
READ	All	III,IV	+0.260	.042	2	view →
KIRP	All	III,IV	+0.056	.013	2	view →
PAAD	Male	All	+0.035	.019	2	view →
PRAD	All	All	−0.025	.006	2	view →
THCA	Female	All	−0.012	.006	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC01168–UCEC

Open the UCEC breakdown →